No Data
No Data
Express News | Cue Biopharma FY24 EPS ($0.72) Up From ($1.11) YoY; Revenue $9.287M Up From $5.490M YoY
Press Release: Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Express News | Cue Biopharma, Inc. Q4 Income From Operations USD -9.633 Million
Express News | Cue Biopharma, Inc. Q4 Operating Expenses USD 11.209 Million
Express News | Cue Biopharma, Inc. Q4 Collaboration Revenue USD 1.576 Million
Express News | Cue Biopharma, Inc. Q4 Basic EPS USD -0.13